Engineered particles are provided may be used for the delivery of a
bioactive agent to the respiratory tract of a patient. The particles may
be used in the form of dry powders or in the form of stabilized
dispersions comprising a nonaqueous continuous phase. In particularly
preferred embodiments the particles may be used in conjunction with an
inhalation device such as a dry powder inhaler, metered dose inhaler or a
nebulizer.